Brief: Kazia Therapeutics Says CEO And Managing Director James Garner Has Resigned
01/05/2023 02:05
May 1 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR JAMES GARNER
HAS
RESIGNED
* JOHN FRIEND WILL IMMEDIATELY ASSUME ROLE OF CEO, AND WILL
IN DUE
COURSE JOIN BOARD AS MANAGING DIRECTOR
Source text for Eikon: ID:nASX2ZCPNx
Further company coverage: KZA.AX
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt